A fungus that causes fungal meningitis, shrinks considerably in size to be able to infect the brain.
- Cryptococcus neoformans, a fungus that causes fungal meningitis, adapts quickly to the microenvironments of the body and shrinks in size to infect the brain
- Researchers are trying to disable the fungus with ready-to-use FDA-approved medications to prevent or treat fungal meningitis
Can Cryptococcus neoformans Adapt to Different Microenvironments in the Body?
The fungus adapts quickly to the microenvironments of the body. The fact that the fungus grows in so many diverse environments is what initially piqued Brown's interest in it. The organism can be found alive in decaying wood and bird droppings in the wild. On accidental inhalation of the fungus, it can persist in the lungs before moving through the circulation to the brain and other organs. Each of these organs have a different microenvironment.In the past, other researchers have discovered that the fungus grows to 10 times its size to survive in the lungs, presumably because it is too big for the host immune system to kill. Nevertheless, fungus cells are significantly smaller in other areas of the body. Brown pondered whether the extra-small size of the cells could serve as a benefit of some sort.
Brown's team discovered that a particular chemical- phosphate-could cause the shift after looking for triggers. Brown hypothesizes that the chemical builds up in the lungs. It is the first place for the fungus to settle after entering the body, because phosphate is released when tissue gets harmed during infection. As a result, the fungal cells might change into seed cells, aiding in infection spread.
Bird Guano’s Role in Aiding Cryptococcus neoformans to Target the Brain
Oddly enough, bird guano may have played a role in the fungus's capacity to target the brain successfully. Pigeon droppings, which contain a lot of the chemical phosphate that activates seed cells, provide a favourable environment for C. neoformans to flourish. Like nothing else they had tried, Brown's team discovered that the sticky material pushes C. neoformans into that other condition.Regardless of how the fungus acquired its spreading capacity, Brown's team is currently attempting to disable it with FDA-approved medications. They are investigating if a substance that prevents C. neoformans from developing into seed cells might already exist. It can be a ready-to-use treatment for preventing or treating fungal meningitis.